American Association for the Advancement of Science, Science Translational Medicine, 470(10), 2018
DOI: 10.1126/scitranslmed.aau5516
Full text: Unavailable
A proteogenomic method identifies potentially actionable tumor-specific antigens and shows that most of them are not coded by classic exons.